Capricor Therapeutics, Inc.
CAPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $20 | $23 | $29 | $11 |
| Short-Term Investments | $79 | $100 | $116 | $140 |
| Receivables | $0 | $0 | $0 | $10 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $1 | $2 |
| Total Curr. Assets | $101 | $124 | $146 | $163 |
| Property Plant & Equip (Net) | $25 | $9 | $7 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $0 | $0 |
| Total NC Assets | $25 | $9 | $8 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $126 | $134 | $154 | $170 |
| Liabilities | – | – | – | – |
| Payables | $3 | $5 | $5 | $8 |
| Short-Term Debt | $0 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $12 | $12 | $12 | $0 |
| Other Curr. Liab. | $13 | $11 | $4 | $12 |
| Total Curr. Liab. | $28 | $28 | $22 | $21 |
| LT Debt | $14 | $0 | $0 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $3 | $3 |
| Total NC Liab. | $14 | $0 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $15 | $1 | $1 | $1 |
| Total Liabilities | $43 | $29 | $26 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$275 | -$250 | -$224 | -$200 |
| AOCI | $1 | $1 | $2 | $1 |
| Other Equity | $358 | $354 | $350 | $344 |
| Total Equity | $84 | $105 | $128 | $145 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $126 | $134 | $154 | $170 |
| Net Debt | -$5 | -$22 | -$28 | -$10 |